Inventiva S.A.
IVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001756594
No open-market purchases or sales by Inventiva S.A. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $319.5M in total; no superinvestor holds it.
Other share classesIVEVF
13F holders, Q4 2025
Institutional positions in Inventiva S.A. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 53
- +38 vs. Q3 2025
- Shares held
- 46.7M
- +41.6M (+814.7%) vs. Q3 2025
- Total value
- $217.2M
- +$187.8M (+638.3%) vs. Q3 2025
- New holders
- 38
- 6 more added
- Sold out
- 0
- 1 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 88 | $319.5M |
| Q1 2026 | 65 | $290.4M |
| Q4 2025 | 53 | $217.2M |
| Q3 2025 | 15 | $29.4M |
| Q2 2025 | 12 | $15.7M |
| Q1 2025 | 8 | $12.2M |
| Q4 2024 | 7 | $11.7M |
| Q3 2024 | 7 | $9.06M |
| Q2 2024 | 7 | $14.5M |
| Q1 2024 | 8 | $17.6M |
| Q4 2023 | 9 | $21.9M |
| Q3 2023 | 8 | $20.6M |
| Q2 2023 | 9 | $19.5M |
| Q1 2023 | 9 | $18.3M |
| Q4 2022 | 7 | $21.9M |
| Q3 2022 | 8 | $33.1M |
| Q2 2022 | 10 | $51.8M |
| Q1 2022 | 10 | $45.0M |
| Q4 2021 | 10 | $51.3M |
| Q3 2021 | 12 | $52.5M |
| Q2 2021 | 14 | $21.3M |
| Q1 2021 | 13 | $23.8M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Inventiva S.A.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Samsara BioCapital, LLC | 5,194,805 | $24.2M | 2.49% | +5,194,805 | New |
| Paradigm Biocapital Advisors LP | 4,000,000 | $18.6M | 0.50% | +4,000,000 | New |
| ADAR1 Capital Management, LLC | 2,709,846 | $12.6M | 0.94% | +2,709,846 | New |
| Trails Edge Capital Partners, LP | 2,657,997 | $12.4M | 3.05% | +2,657,997 | New |
| Millennium Management LLC | 2,652,570 | $12.3M | 0.01% | +2,540,540+2,267.7% | Added |
| UBS Group AG | 2,643,702 | $12.3M | 0.00% | +2,634,580+28,881.6% | Added |
| SymBiosis Capital Partners, LLC | 2,600,000 | $12.1M | 11.04% | +2,600,000 | New |
| Franklin Resources Inc | 2,500,141 | $11.6M | 0.00% | +2,500,141 | New |
| Caligan Partners LP | 2,000,000 | $9.30M | 0.85% | +2,000,000 | New |
| Polar Capital Holdings Plc | 1,998,880 | $9.29M | 0.04% | +1,998,880 | New |
| Andera Partners | 1,818,181 | $8.45M | 4.79% | +1,818,181 | New |
| Fan Yu | 1,500,000 | $6.97M | 7.56% | +1,500,000 | New |
| Ally Bridge Group (NY) LLC | 1,500,000 | $6.97M | 11.07% | +1,500,000 | New |
| NEA Management Company, LLC | 1,462,586 | $6.80M | 0.35% | 00.0% | Unchanged |
| RTW Investments, LP | 1,298,701 | $6.04M | 0.06% | +1,298,701 | New |
| NEXTBio Capital Management LP | 1,298,701 | $6.04M | 3.54% | +1,298,701 | New |
| Propel Bio Management, LLC | 1,000,000 | $4.65M | 3.97% | +1,000,000 | New |
| BVF Inc | 686,040 | $3.19M | 0.11% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 658,971 | $3.06M | 0.08% | +658,971 | New |
| Ameriprise Financial Inc | 615,473 | $2.86M | 0.00% | +615,473 | New |
| J. Goldman & Co LP | 516,445 | $2.40M | 0.09% | +516,445 | New |
| Morgan Stanley | 507,701 | $2.36M | 0.00% | +477,921+1,604.8% | Added |
| Ikarian Capital, LLC | 502,601 | $2.33M | 0.30% | +502,601 | New |
| Alyeska Investment Group, L.P. | 500,000 | $2.33M | 0.01% | +500,000 | New |
| Deep Track Capital, LP | 490,000 | $2.28M | 0.05% | +490,000 | New |
| StemPoint Capital LP | 467,242 | $2.17M | 0.37% | +436,418+1,415.8% | Added |
| Goldman Sachs Group Inc | 429,595 | $2.00M | 0.00% | +429,595 | New |
| Simplify Asset Management Inc. | 337,662 | $1.57M | 0.03% | +337,662 | New |
| Diadema Partners LP | 334,251 | $1.55M | 0.93% | +334,251 | New |
| Squadron Capital Management LLC | 300,000 | $1.40M | 0.62% | +300,000 | New |
| Saturn V Capital Management LLC | 283,166 | $1.32M | 0.24% | +283,166 | New |
| Yiheng Capital Management, L.P. | 255,915 | $1.19M | 0.52% | −2,389,011−90.3% | Reduced |
| Eventide Asset Management, LLC | 250,000 | $1.16M | 0.02% | +250,000 | New |
| Marshall Wace, LLP | 172,093 | $800.2K | 0.00% | +172,093 | New |
| Persistent Asset Partners Ltd | 129,711 | $603.2K | 0.29% | +129,711 | New |
| Superstring Capital Management LP | 100,000 | $465.0K | 0.25% | +100,000 | New |
| Commonwealth Equity Services, LLC | 77,561 | $360.7K | 0.00% | +12,704+19.6% | Added |
| Quadrature Capital Ltd | 66,929 | $311.2K | 0.00% | +66,929 | New |
| Two Sigma Investments, LP | 57,417 | $267.0K | 0.00% | +57,417 | New |
| Wealth Enhancement Advisory Services, LLC | 25,770 | $117.0K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 20,000 | $93.0K | 0.00% | 00.0% | Unchanged |
| Cerity Partners LLC | 20,000 | $93.0K | 0.00% | +20,000 | New |
| XTX Topco Ltd | 18,053 | $83.9K | 0.00% | +18,053 | New |
| Citadel Advisors LLC | 14,699 | $68.3K | 0.00% | +14,699 | New |
| Virtu Financial LLC | 12,869 | $60.0K | 0.00% | +12,869 | New |
| AQR Capital Management LLC | 10,000 | $46.5K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 10,000 | $46.5K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 2,632 | $12.2K | 0.00% | +2,482+1,654.7% | Added |
| GAMMA Investing LLC | 1,780 | $8.28K | 0.00% | +1,780 | New |
| Covestor Ltd | 402 | $2.00K | 0.00% | 00.0% | Unchanged |
| Atlantic Union Bankshares Corp | 300 | $1.40K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 44 | $205 | 0.00% | +44 | New |
| Citigroup Inc | 1 | $5 | 0.00% | +1 | New |